When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden? Guidelines based on Delphi Consensus A Delphi Consensus was created to establish guidelines on fluorescence imaging of bacterial burden (MolecuLight i:X), the only point-of-care solution to visualize the presence of significant bacterial burden (>104 CFU/g) in wounds.
Join 5 of the authors of the Delphi Consensus as they discuss:
- Clinical indications for fluorescence imaging (e.g., delayed wound healing, before and after debridement, before placement of cellular and tissue-based products)
- Recommended frequency of fluorescence imaging
- Real-world impact of fluorescence imaging on clinical decision making and associated wound outcomes